Enhanze
Navigation Links
Enhanze in Medical News
Halozyme Therapeutics to Hold Pipeline Update Conference Call on August 8
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics Added to Nasdaq Biotech Index
...covering the family of human enzymes known as hyaluronidases. The company's enhanze Technology is a novel drug delivery platform designed to increase the absor...logical therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10...Baxter Reports Strong Third Quarter Sales and Earnings
...wn as KIOVIG(TM) in Europe). For patients using GAMMAGARD LIQUID 10% - currently administered intravenously - subcutaneous administration with enhanze Technology may increase convenience and improve the dispersion of the therapy. -- A collaboration with DEKA Research & Development Corp. and HHD...Enhanze in Medical Technology
- Co-Injection of rHuPH20 with Humira Estimated to Increase the
Maximal Steady State Subcutaneous Bioavailability from 64% to 100%
-
SAN DIEGO, July 09, 2007 /PRNewswire-FirstCall/ -- Halozyme
Therapeutics, Inc. , a biopharmaceutical company developing and
commercializing recombinant human enzymes...
...an enzymes known as hyaluronidases. The company's enhanze Technology is a novel drug delivery platform desig...ics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compo...unds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic comp...
...hase 1 pharmacokinetic clinical trial with a subcutaneous formulation using enhanze Technology of a biologic directed to a Roche exclusive target. This has tri...logical therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic product, GAMMAGARD LIQUID 10%...
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...
... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
...an enzymes known as hyaluronidases. The company's enhanze Technology is a novel drug delivery platform desig...ics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compo...unds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic comp...
...hase 1 pharmacokinetic clinical trial with a subcutaneous formulation using enhanze Technology of a biologic directed to a Roche exclusive target. This has tri...logical therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic product, GAMMAGARD LIQUID 10%...
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape......nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...
... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously
... Phase I/II data showed that enhanze Technology(TM) enabled subcutaneous administrat... administered combination of GAMMAGARD LIQUID with enhanze Technology was 92 percent of the traditional, mont...ivotal Phase III trial using GAMMAGARD LIQUID with enhanze Technology pending discussions with regulatory aut...... key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cum...
Enhanze in Biological Technology
Halozyme Receives $5.5 Million Payment From Baxter
...s that affect the extracellular matrix. Halozyme's enhanze Technology is a novel drug delivery platform desi...e company has key partnerships with Roche to apply enhanze Technology to Roche's biological therapeutic compo... to 13 targets and with Baxter BioScience to apply enhanze Technology to Baxter's biological therapeutic comp...Phase III Trial Begins for GAMMAGARD LIQUID Plus rHuPH20 in Primary Immunodeficiency Patients
...neous (SC) administration of GAMMAGARD LIQUID with enhanze Technology is an investigational study and when ap...gics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compo...unds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic comp...Halozyme Therapeutics Reports 2008 Third Quarter Financial Results
...n and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply enhanze Technology to Baxter's biological therapeutic product, GAMMAGARD LIQUID 10%......nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...
Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics to Present at Upcoming Investor Conferences
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics to Host Research Day for Investors and Analysts
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics to Present at Upcoming Investor Conferences
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
...nology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therape...Other TagsAlmondsAwarenessRectalRectalRectalRectalBenefitsBenefitsBenefitsBenefitsAttitudeInfluenceInfluenceVacuumBreastfedPsychiatricNursesMarriageOther Contentsgoutgoutinguinalegrassgrassgrassgrassgrassgriefgriefgrippepainspainspainspainsgrowinggrowinggrowinggrowinggrowinggrowinggrowinggrowinggrowinggrowinghalitosishalitosis
AlmondsAwarenessRectalBenefitsGingkoAttitudeInfluenceVacuumBreastfedPsychiatricNiacinHummingNursesMarriage
(Date:12/4/2009)... , NEW YORK, Dec. 4 Thousands ...0 offices nationwide today, to participate in a co...x and advisory firm,s support for literacy with ch... reflects our firm,s long history of volunteerism....d in the spirit of caring to brighten the holidays...
(Date:12/4/2009)..., SCOTTSDALE, Ariz., Dec. 4 Hea...aged, non-traded, real estate investment trust, an...ment to acquire a three building medical office po...exas, and Fort Wayne, Indiana for approximately $2...ect to the satisfaction of a number of conditions....
(Date:12/4/2009)... , WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ ...rm would control health care costs, Leapfrog,s pur...ough example -- delivering the best quality care i... efficiency. Thirty-four urban, eight children,s a...frog Top Hospitals, based on results from The Leap...
(Date:12/4/2009)...king with mice, scientists at Johns Hopkins publis...wn that a protein made by a gene called "Twist" ma...istinguish stem cells that drive aggressive, metas.... , Building on recent work suggesting that it i...st tumors that drives breast cancer, scientists ha...
(Date:12/4/2009)... Dental tourism is a phenomenon ...n alternative to the high price of dental work in ...ch for lower priced dental care, people have found... a dental tourist destination. , ... business for more than 6 years, Mexican Dental Va...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3[0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children[0] Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana[0] The Leapfrog Group Releases Its 2009 Top Hospitals List[0] Potential new 'twist' in breast cancer detection[0] Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor
(Date:12/3/2009)...ntists believe that staph infections are caused by...it toxins. The signaling process is called quorum ...tart the process. , But the Jeff Brinker researc...f staph infection, when bacteria switch from a har...and that this individual process can be stopped by...
(Date:12/3/2009)...ed in the design of the upcoming forest deal at Co...according to a scientist at the University of Leed...argues that at least 50% of the carbon credit paym...ducing Emissions from Deforestation and Degredatio...d their property rights assured. , "There is the...
(Date:12/3/2009)...rctic snowmelt that occurred during the 2008-09 au...ositive phases for two main climate drivers, ENSO ...Hemisphere Annular Mode), according to Dr. Marco T... Sciences at The City College of New York. , P...lty at the CUNY Graduate Center, added that Antarc...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2CCNY professor foresees rising Antarctic snowmelt 2Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 1Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 2Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 3Technology Collaborative Launches Online Game to Exercise Brain Power of People with Multiple Sclerosis 51897 42009 National Ergonomics Conference Schedule Announced Focus on Productivity 26 Profitability With Reduced Workforces All Major Sponsors Renew 26 51893 12009 National Ergonomics Conference Schedule Announced Focus on Productivity 26 Profitability With Reduced Workforces All Major Sponsors Renew 26 51893 2Teaming Up to Tackle a Deadly Cancer 51891 1Teaming Up to Tackle a Deadly Cancer 51891 2Teaming Up to Tackle a Deadly Cancer 51891 3Teaming Up to Tackle a Deadly Cancer 51891 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |